Clinical Trials
2 trialsNCT02253316 2025-11-10
Phase II Study of IRD (Ixazomib, Lenalidomide, Dexamethasone) Post Autologous Stem Cell Transplantation Followed by Maintenance Ixazomib or Lenalidomide for Multiple Myeloma
Washington University School of Medicine
Phase 2 Active not recruiting
NCT06594315 2025-09-18
Assessing Brain Metabolism Using MRS With Deuterated Glucose
University of California, San Francisco
Active not recruiting